NCT04248920

Brief Summary

Analysis of emergency department (ED) visits with a billing code for 'epilepsy' or 'seizure' found up to 37% are eligible for deferral. This study is a randomized controlled trial (RCT) of the Clinic To Community© program (C2C) as an intervention for adults with epilepsy visiting emergency departments at a mid size hospital in Ontario, Canada. Participants in the intervention arm receive patient education to improve knowledge of epilepsy and access to community-based services. Participants in the control group are wait-listed and receive patient education 12 months later. The study objective is to successfully implement, recruit and retain participants for this intervention and evaluate whether C2C will reduce the frequency of ED visits, reduce felt stigma and improve quality of life, epilepsy knowledge, and self-management skills.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
9

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Sep 2022

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

January 15, 2020

Completed
15 days until next milestone

First Posted

Study publicly available on registry

January 30, 2020

Completed
2.6 years until next milestone

Study Start

First participant enrolled

September 12, 2022

Completed
1.2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 11, 2023

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 11, 2023

Completed
Last Updated

January 3, 2024

Status Verified

January 1, 2024

Enrollment Period

1.2 years

First QC Date

January 15, 2020

Last Update Submit

January 2, 2024

Conditions

Keywords

Health Care UtilizationEmergency Department

Outcome Measures

Primary Outcomes (1)

  • Rate of engagement with the Clinic To Community© (C2C) program

    Evaluated by rate of ED referrals, rate of recruitment, rate of retention, and proportion who receive support education.

    Throughout study completion, approximately 2 years

Secondary Outcomes (6)

  • Frequency of epilepsy-related emergency department (ED) visits over the next 12 months

    Baseline (0), and 12 months

  • Effect of participation in C2C on felt stigma using "Stigma Scale of Epilepsy"

    Baseline (0) and 12 months

  • Effect of participation in C2C on felt stigma using "Epilepsy Stigma Scale"

    Baseline (0) and 12 months

  • Effect of participation in C2C on self-management skills

    Baseline (0) and 12 months

  • Effect of participation in C2C on quality of life

    Baseline (0) and 12 months

  • +1 more secondary outcomes

Other Outcomes (7)

  • Effect on quality of life using World Health Organization Quality of Life (WHOQOL)

    Baseline (0) and 12 months

  • Effect on activities of daily living using Sheehan Disability Scale

    Baseline (0) and 12 months

  • Effect on anxiety using Generalized Anxiety Disorder 7-item (GAD-7) scale

    Baseline (0) and 12 months

  • +4 more other outcomes

Study Arms (2)

Intervention Group

EXPERIMENTAL

Intervention Group. Participants randomized to the intervention group will complete the C2C program. They will receive an in-person one-on-one 60-minute education session and will be introduced to, and encouraged to participate in, the programs and support services that are provided by Epilepsy Southwestern Ontario (ESWO). As part of the C2C program, participants will be contacted 6 months later for a supplementary consultation over the telephone and to answer any questions. Epilepsy is unique among chronic, episodic disorders in that PWE lose their ability to make choices during a seizure and depend to a greater degree on the decisions of others including family, friends and colleagues. For this reason, we encourage the PWE to invite their support network to attend the patient education sessions.

Behavioral: Clinic to Community Education Program

Waitlist Control Group

OTHER

Waitlist Control Group. The control group continues TAU and will be followed up 12 months after randomization. The control group will receive C2C after the 12-month follow-up.

Behavioral: Clinic to Community Education Program

Interventions

The C2C program aims to improve participants' knowledge of epilepsy and access to services and to provide support. Participants randomized to the intervention group will complete the C2C program. They will receive an in-person one-on-one 60-minute education session and will be introduced to, and encouraged to participate in, the programs and support services that are provided by Epilepsy Southwestern Ontario (ESWO).

Intervention GroupWaitlist Control Group

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Adults (aged ≥18 years) visiting a participating ED for a seizure or an epilepsy-related concern.
  • Adults on anti-seizure medication prior to coming to the ED or prescribed anti-seizure medication at the ED.
  • Providing informed consent and having sufficient English language skills to complete questionnaires and participate in the intervention.

You may not qualify if:

  • Previous participation in the C2C program.
  • Known diagnosis of psychogenic non-epileptic seizures (PNES).

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

London Health Sciences Centre

London, Ontario, N6A 5W9, Canada

Location

Related Publications (5)

  • Bautista RE, Glen ET, Wludyka PS, Shetty NK. Factors associated with utilization of healthcare resources among epilepsy patients. Epilepsy Res. 2008 May;79(2-3):120-9. doi: 10.1016/j.eplepsyres.2008.01.003. Epub 2008 Mar 12.

    PMID: 18339521BACKGROUND
  • Bowen JM, Snead OC, Chandra K, Blackhouse G, Goeree R. Epilepsy care in ontario: an economic analysis of increasing access to epilepsy surgery. Ont Health Technol Assess Ser. 2012;12(18):1-41. Epub 2012 Jul 1.

    PMID: 23074428BACKGROUND
  • Couldridge L, Kendall S, March A. A systematic overview--a decade of research'. The information and counselling needs of people with epilepsy. Seizure. 2001 Dec;10(8):605-14. doi: 10.1053/seiz.2001.0652.

    PMID: 11792167BACKGROUND
  • Noble AJ, Mathieson A, Ridsdale L, Holmes EA, Morgan M, McKinlay A, Dickson JM, Jackson M, Hughes DA, Goodacre S, Marson AG. Developing patient-centred, feasible alternative care for adult emergency department users with epilepsy: protocol for the mixed-methods observational 'Collaborate' project. BMJ Open. 2019 Nov 2;9(11):e031696. doi: 10.1136/bmjopen-2019-031696.

    PMID: 31678950BACKGROUND
  • Kapoor, Deepa, Joubert, Gary, Thind, Amardeep, Secco, Mary, Speechley, Kathy Nixon. Number of Potentially Deferrable Patients Presenting to Emergency Departments in London with Seizures. Epilepsia 2007; Vol 48, Supplement 6

    BACKGROUND

MeSH Terms

Conditions

Epilepsy, GeneralizedPatient Acceptance of Health CareEmergencies

Condition Hierarchy (Ancestors)

EpilepsyBrain DiseasesCentral Nervous System DiseasesNervous System DiseasesTreatment Adherence and ComplianceHealth BehaviorBehaviorDisease AttributesPathologic ProcessesPathological Conditions, Signs and Symptoms

Study Officials

  • Kathy N Speechley, PhD

    London Health Sciences Centre

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Masking Details
Due to the nature of the intervention, it is not feasible for participants and study personnel to be blinded. However, the letter of information (LOI) indicates that the study aims to evaluate outcomes after an ED visit, and, in addition, evaluate the impact of a community engagement program.
Purpose
SUPPORTIVE CARE
Intervention Model
PARALLEL
Model Details: This is a parallel, pilot randomized controlled trial (RCT) comparing the Clinic To Community© program plus treatment-as-usual (TAU) with TAU only (i.e. wait-list control).
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

January 15, 2020

First Posted

January 30, 2020

Study Start

September 12, 2022

Primary Completion

December 11, 2023

Study Completion

December 11, 2023

Last Updated

January 3, 2024

Record last verified: 2024-01

Data Sharing

IPD Sharing
Will share

This study is partnered with the Ontario Brain Institute (OBI). Study data and other personal health information collected as a part of this research study will be shared with the Ontario Brain Institute. OBI is a not-for profit research institute that funds people to work together to find cures and better treatments for brain disorders. It includes not just doctors and researchers but patients, members of the medical community, government and other health-related organizations. This database of research data is known as 'Brain-CODE'. Brain-CODE is an open-access database. This means that researchers and organizations outside of this study can request access to study data that is in the Brain-CODE database. OBI may take data, combine it with data from many other people, and make it available to enhance the public's awareness of research. They will use tools to remove identifying information from these combined data sets, making the risk of identifiers minimal.

Shared Documents
SAP, ICF
Time Frame
Data will be stored in BrainCODE indefinitely
Access Criteria
Access to data by outside researchers or organizations will require a detailed plan for the use of the data, and approval from a research ethics board, as described in OBI's Data Sharing Policy http://www.braininstitute.ca/Brain-CODE-governance. These researchers or organizations will be required to enter into an agreement with OBI that clearly states the safeguards that will be in place to protect that data, and the purposes for which this data may be collected, used, stored and disclosed.
More information

Locations